+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Antacids - Global Strategic Business Report - Product Thumbnail Image

Antacids - Global Strategic Business Report

  • Report
  • October 2026
  • 486 Pages
  • Global
From
From
Antidiuretic Drugs - Global Strategic Business Report - Product Thumbnail Image

Antidiuretic Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 178 Pages
  • Global
From
Digestive Health Products - Global Strategic Business Report - Product Thumbnail Image

Digestive Health Products - Global Strategic Business Report

  • Report
  • October 2026
  • 297 Pages
  • Global
From
Methotrexate Drugs - Global Strategic Business Report - Product Thumbnail Image

Methotrexate Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 564 Pages
  • Global
From
Diabetic Ulcers Treatment - Global Strategic Business Report - Product Thumbnail Image

Diabetic Ulcers Treatment - Global Strategic Business Report

  • Report
  • October 2026
  • 384 Pages
  • Global
From
Erdosteine - Global Strategic Business Report - Product Thumbnail Image

Erdosteine - Global Strategic Business Report

  • Report
  • October 2026
  • 274 Pages
  • Global
From
Cannabidiol (CBD) Pet - Global Strategic Business Report - Product Thumbnail Image

Cannabidiol (CBD) Pet - Global Strategic Business Report

  • Report
  • October 2026
  • 383 Pages
  • Global
From
Acitretin - Global Strategic Business Report - Product Thumbnail Image

Acitretin - Global Strategic Business Report

  • Report
  • October 2026
  • 470 Pages
  • Global
From
Non-opioid Pain Treatment - Global Strategic Business Report - Product Thumbnail Image

Non-opioid Pain Treatment - Global Strategic Business Report

  • Report
  • October 2026
  • 480 Pages
  • Global
From
Montelukast Sodium - Global Strategic Business Report - Product Thumbnail Image

Montelukast Sodium - Global Strategic Business Report

  • Report
  • October 2026
  • 278 Pages
  • Global
From
Celiac Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Celiac Disease Treatment - Global Strategic Business Report

  • Report
  • October 2026
  • 371 Pages
  • Global
From
From
Catecholamines - Global Strategic Business Report - Product Thumbnail Image

Catecholamines - Global Strategic Business Report

  • Report
  • October 2026
  • 372 Pages
  • Global
From
Dacryocystitis - Global Strategic Business Report - Product Thumbnail Image

Dacryocystitis - Global Strategic Business Report

  • Report
  • October 2026
  • 374 Pages
  • Global
From
From
Hyperhidrosis Treatment - Global Strategic Business Report - Product Thumbnail Image

Hyperhidrosis Treatment - Global Strategic Business Report

  • Report
  • October 2026
  • 480 Pages
  • Global
From
Cyclooxygenase 1 Inhibitors - Global Strategic Business Report - Product Thumbnail Image

Cyclooxygenase 1 Inhibitors - Global Strategic Business Report

  • Report
  • October 2026
  • 367 Pages
  • Global
From
Hemangioma Treatment - Global Strategic Business Report - Product Thumbnail Image

Hemangioma Treatment - Global Strategic Business Report

  • Report
  • October 2026
  • 485 Pages
  • Global
From
Migraine Drugs - Global Strategic Business Report - Product Thumbnail Image

Migraine Drugs - Global Strategic Business Report

  • Report
  • October 2026
  • 500 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more